DENDREON TARGETING CANCER, TRANSFORMING LIVES Trademark

Trademark Overview


On Saturday, October 17, 2020, a trademark application was filed for DENDREON TARGETING CANCER, TRANSFORMING LIVES with the United States Patent and Trademark Office. The USPTO has given the DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark a serial number of 90260940. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2023. This trademark is owned by Dendreon Pharmaceuticals LLC. The DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy, immunopharmaceuticals, and vaccines; Research, development, engineering and testing services in the fields of gene therapy, immunopharmaceuticals, and vaccines
dendreon targeting cancer, transforming lives

General Information


Serial Number90260940
Word MarkDENDREON TARGETING CANCER, TRANSFORMING LIVES
Filing DateSaturday, October 17, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements


Description of MarkThe mark consists of the term "Dendreon" having an upper case "D" and lower case "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e", "o" and "n" the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n" resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case.
Goods and ServicesTesting, inspection, research, or development of pharmaceutical preparations for gene therapy, immunopharmaceuticals, and vaccines; Research, development, engineering and testing services in the fields of gene therapy, immunopharmaceuticals, and vaccines

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 4, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDendreon Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSeal Beach, CA 90740

Party NameDendreon Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSeal Beach, CA 90740

Trademark Events


Event DateEvent Description
Tuesday, January 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, May 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 4, 2022SOU EXTENSION 2 GRANTED
Wednesday, May 4, 2022SOU EXTENSION 2 FILED
Wednesday, May 4, 2022TEAS EXTENSION RECEIVED
Friday, December 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 15, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 15, 2021SOU EXTENSION 1 FILED
Wednesday, December 15, 2021TEAS EXTENSION RECEIVED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 8, 2021ASSIGNED TO EXAMINER
Saturday, December 5, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, December 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, October 21, 2020NEW APPLICATION ENTERED IN TRAM